Evidence map›Paper›PMID 27363485›Full record

ArticleScientific reports2016

Catalysts of DNA Strand Cleavage at Apurinic/Apyrimidinic Sites.

Irina G Minko, Aaron C Jacobs, Arnie R de Leon, Francesca Gruppi, Nathan Donley, Thomas M Harris, Carmelo J Rizzo, Amanda K McCullough, R Stephen Lloyd

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Telomerase mRNA therapy protects human skin against radiation-induced DNA damage.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Analytical chemistry · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Irina G MinkoOregon Institute of Occupational Health Sciences, Oregon Health &Science University, Portland, Oregon 97239, United States.
Aaron C JacobsOregon Institute of Occupational Health Sciences, Oregon Health &Science University, Portland, Oregon 97239, United States.
Arnie R de LeonDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee 37235, United States.
Francesca GruppiDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee 37235, United States.
Nathan DonleyOregon Institute of Occupational Health Sciences, Oregon Health &Science University, Portland, Oregon 97239, United States.
Thomas M HarrisDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee 37235, United States.
Carmelo J RizzoDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee 37235, United States.
Amanda K McCulloughOregon Institute of Occupational Health Sciences, Oregon Health &Science University, Portland, Oregon 97239, United States.
R Stephen LloydOregon Institute of Occupational Health Sciences, Oregon Health &Science University, Portland, Oregon 97239, United States.

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Structural Biology Facility CoreP30ES000267 · NIEHS · VANDERBILT UNIVERSITY · PI GUENGERICH, F PETER · 1985 to 2014
$20.3M
Synthetic Approaches to Carcinogen-Linked OligonucleotidesP01CA160032 · NCI · VANDERBILT UNIVERSITY · PI STONE, MICHAEL P · 2012 to 2022
$14.0M
MODE OF ACTION OF ENVIRONMENTAL TOXICANTST32ES007060 · NIEHS · OREGON STATE UNIVERSITY · PI Jamie DeWitt, Siva Kumar Kolluri · 1985 to 2026
$11.6M
Training in the Molecular Basis of Skin/Mucosa PathobiologyT32CA106195 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI KULESZ-MARTIN, MOLLY F. · 2004 to 2018
$3.8M
NCI NIH HHS P01 CA160032NCI NIH HHS P30 CA068485NCI NIH HHS T32 CA106195NIEHS NIH HHS P30 ES000267NIEHS NIH HHS T32 ES007060
6 · The paper itself

Abstract

Apurinic/apyrimidinic (AP) sites are constantly formed in cellular DNA due to instability of the glycosidic bond, particularly at purines and various oxidized, alkylated, or otherwise damaged nucleobases. AP sites are also generated by DNA glycosylases that initiate DNA base excision repair. These lesions represent a significant block to DNA replication and are extremely mutagenic. Some DNA glycosylases possess AP lyase activities that nick the DNA strand at the deoxyribose moiety via a β- or β,δ-elimination reaction. Various amines can incise AP sites via a similar mechanism, but this non-enzymatic cleavage typically requires high reagent concentrations. Herein, we describe a new class of small molecules that function at low micromolar concentrations as both β- and β,δ-elimination catalysts at AP sites. Structure-activity relationships have established several characteristics that appear to be necessary for the formation of an iminium ion intermediate that self-catalyzes the elimination at the deoxyribose ring.

Indexed as

DNA CleavageDNA DamageDNA RepairApurinic AcidBase SequenceBinding SitesBiocatalysisDNADNA-(Apurinic or Apyrimidinic Site) LyaseApurinic AcidDNADNA-(Apurinic or Apyrimidinic Site) Lyase

Identifiers

PMID27363485
PMCPMC4929455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.